The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir Treatment

This study has been completed.
Information provided by NIH AIDS Clinical Trials Information Service

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Herpes Simplex
			HIV Infections
2		Additional conditions recognized in this trial
			Acquired Immunodeficiency Syndrome
			Communicable Diseases
			Infection
			Virus Diseases
3		More general conditions related to this trial
			DNA Virus Infections
			Herpesviridae Infections
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Lentivirus Infections
			Retroviridae Infections
			RNA Virus Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Viral
			Skin Diseases
			Skin Diseases, Infectious
			Skin Diseases, Viral
			Slow Virus Diseases
4		Interventions listed in this trial
			Foscarnet sodium
5		Additional drug interventions recognized in this trial
			Foscarnet
			Phosphonoacetic Acid
6		More general drug interventions related to this trial
			Anti-Infective Agents
			Anti-Retroviral Agents
			Antiviral Agents
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Reverse Transcriptase Inhibitors
			Therapeutic Uses
7		Sponsors listed in this trial
			Astra USA